- Record: found
- Abstract: found
- Article: not found
Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 4007 trial.
Shuichi Hironaka
1 ,
Shinya Ueda ,
Hirofumi Yasui ,
Tomohiro Nishina ,
Masahiro Tsuda ,
Takehiko Tsumura ,
Naotoshi Sugimoto ,
Hideki Shimodaira ,
Shinya Tokunaga ,
Toshikazu Moriwaki ,
Taito Esaki ,
Michitaka Nagase ,
Kazumasa Fujitani ,
Kensei Yamaguchi ,
Takashi Ura ,
Yasuo Hamamoto ,
Satoshi Morita ,
Isamu Okamoto ,
Narikazu Boku ,
Ichinosuke Hyodo
Dec 10 2013
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
This phase III study compared treatment with weekly paclitaxel and biweekly irinotecan in patients with advanced gastric cancer refractory to treatment with fluoropyrimidine plus platinum.